Heartflow, Inc.
46.67USD
-1.0800 (-2.26%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.1▲ | $-0.11 | 4 | 2 |
| Next quarter | $-0.09▼ | $-0.09 | 1 | 4 |
| Current year | $-0.42▲ | $-0.49 | 6 | 0 |
| Next year | $-0.26▲ | $-0.26 | 3 | 3 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.13 | $-0.07 | +0.06 (+47.8%) |
| 2026-03-31 | $-0.17 | $-0.16 | +0.01 (+8.5%) |
| 2025-12-31 | $-0.16 | $-0.12 | +0.04 (+23.2%) |
| 2025-09-30 | $-0.24 | $-0.27 | -0.03 (-12.5%) |
24 ratings from 9 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | $37 $45 | Aug 14, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $35 $40 | Aug 14, 2026 |
| Piper Sandler | Reiterated | Overweight | $38 $45 | Aug 14, 2026 |
| JP Morgan | Maintained | Overweight | $35 $45 | Aug 14, 2026 |
| Wells Fargo | Maintained | Overweight | $37 $39 | Aug 14, 2026 |
| Stifel | Maintained | Buy | $40 $45 | Aug 14, 2026 |
| Baird | Initiated | Outperform | $34 | Jul 31, 2026 |
| Freedom Capital Markets | Initiated | Buy | $37 | Jul 1, 2026 |
| Canaccord Genuity | Maintained | Buy | $43 $37 | May 15, 2026 |
| Wells Fargo | Maintained | Overweight | $35 $37 | May 15, 2026 |
| William Blair | Initiated | Outperform | — | May 4, 2026 |
| JP Morgan | Maintained | Overweight | $40 $35 | Mar 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $40 $43 | Mar 19, 2026 |
| Wells Fargo | Maintained | Overweight | $38 $35 | Mar 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $40 | Mar 9, 2026 |
| Wells Fargo | Initiated | Overweight | $38 | Jan 28, 2026 |
| Canaccord Genuity | Maintained | Buy | $39 $40 | Nov 13, 2025 |
| JP Morgan | Maintained | Overweight | $36 $40 | Nov 13, 2025 |
| Stifel | Maintained | Buy | $35 $40 | Nov 13, 2025 |
| Canaccord Genuity | Maintained | Buy | $35 $39 | Sep 22, 2025 |
| Stifel | Initiated | Buy | $35 | Sep 2, 2025 |
| Canaccord Genuity | Initiated | Buy | $35 | Sep 2, 2025 |
| Piper Sandler | Initiated | Overweight | $38 | Sep 2, 2025 |
| JP Morgan | Initiated | Overweight | $36 | Sep 2, 2025 |
60 filings from 12 insiders · 18 buy / 18 sell over 6m
Officers and directors of HTFL, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Verghese VikramOfficer, Chief Financial Officer | Sell | 27.5k | $49.69 | $1.37M | Sep 3, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 5.9k | $50.60 | $297k | Sep 2, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 27.2k | $50.00 | $1.36M | Aug 21, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 32.7k | $45.00 | $1.47M | Aug 18, 2026 |
| ROGERS CAMPBELL M.D.Officer | Sell | 9.2k | $41.23 | $380k | Aug 17, 2026 |
| ROGERS CAMPBELL M.D.Officer | Exercise | 9.2k | $19.00 | $175k | Aug 17, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 15.6k | $39.06 | $608k | Aug 14, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 22.6k | $28.31 | $639k | Aug 10, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Exercise | 31.2k | $2.22 | $158k | Jul 30, 2026 |
| VERGHESE VIKRAMChief Financial Officer | Exercise | 22.5k | $2.22 | $50k | Jul 27, 2026 |
| LIGHTCAP JEFFREY CDirector | Exercise | 47.4k | $19.00 | $901k | Jul 24, 2026 |
| BARABE TIMOTHY CRAIGDirector | Exercise | 3.7k | $19.00 | $70k | Jul 22, 2026 |
| VERGHESE VIKRAMChief Financial Officer | Exercise | 22.5k | $2.22 | $50k | Jul 21, 2026 |
| BARABE TIMOTHY CRAIGDirector | Exercise | 5.0k | $19.00 | $95k | Jul 17, 2026 |
| ROGERS CAMPBELL M.D.Officer | Sell | 9.2k | $25.72 | $237k | Jul 15, 2026 |
| ROGERS CAMPBELL M.D.Officer | Exercise | 9.2k | $19.00 | $175k | Jul 15, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 22.6k | $27.75 | $626k | Jul 10, 2026 |
| WELDON WILLIAM CONRADDirector | Exercise | 51.4k | $8.33 | $428k | Jul 8, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 38.9k | $35.00 | $1.36M | Jun 24, 2026 |
| ROGERS CAMPBELL M.D.Officer | Exercise | 10.0k | $2.22 | $22k | Jun 15, 2026 |
No analyst notes on HTFL yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
| 1 mo ago | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
| 2 mo ago | 2 | 5 | 1 | 0 | 0 | Buy1.88 |